ZimVie

Westminster, United States Founded: 2022 • Age: 4 yrs Acquired By ARCHIMED
Implants for dental and spine treatments are developed.
Annual revenue $449.8M Latest available
Total funding - Funding intelligence
Employees 1770 Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About ZimVie

ZimVie is a company based in Westminster (United States) founded in 2022 was acquired by ARCHIMED in July 2025. The company has 1,770 employees as of December 31, 2024. ZimVie offers products and services including Implant Systems, RealGUIDE Software, and RegenerOss Allograft Putty. ZimVie operates in a competitive market with competitors including Nevro, ATEC Spine, Sonendo, Vertos Medical and Paradigm Spine, among others.

  • Headquarter Westminster, United States
  • Employees 1770 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zimvie Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $449.75 M (USD)
    -1.68
    as on Dec 31, 2024
  • Net Profit
    -$36.9 M (USD)
    90.62
    as on Dec 31, 2024
  • EBITDA
    $32.21 M (USD)
    -70.83
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    1770

    as on Dec 31, 2024

  • Acquired by
    ARCHIMED

    & 1 more

    (Jul 21, 2025)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of ZimVie

ZimVie is a publicly listed company on the NASDAQ with ticker symbol ZIMV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: ZIMV · Sector: Health technology · USA

Products & Services of ZimVie

ZimVie offers a comprehensive portfolio of products and services, including Implant Systems, RealGUIDE Software, and RegenerOss Allograft Putty.

Primary

Systems for tooth replacement and rehabilitation procedures.

Software for efficient implant surgery and restorative design.

Moldable bone matrix for dental grafting applications.

People of ZimVie

Headcount 200-500
Employee Profiles 130
Employee Profiles
People
Amanda Lynch
Territory Manager
People
Sonia Gascón Rius
EMEA Dental FP A Lead EMEA
People
Daniel M Clotfelter
Sr Oracle Financial Lead
People
Lisa Lambert - Gussie
Information Technology Technician & Hipaa Specialist

Unlock access to complete

Funding Insights of ZimVie

Investors in ZimVie

ZimVie has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include H.I.G. Capital and ARCHIMED.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Healthcare industries are funded and supported globally by ARCHIMED.
Founded Year Domain Location

Investments & Acquisitions by ZimVie

Investments

Financial Statements - ZimVie

Zimvie Comparisons

+
Add Comparison
Available on Premium

Competitors of ZimVie

ZimVie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Sonendo, Vertos Medical and Paradigm Spine, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of high-frequency spinal cord stimulation implants
domain founded_year HQ Location
Treatment solutions for spine disorders are developed.
domain founded_year HQ Location
Therapy devices and software for treating tooth decay are developed.
domain founded_year HQ Location
Minimally invasive treatments for lumbar spinal stenosis are developed.
domain founded_year HQ Location
Stabilization devices for healthcare are manufactured by the company.
domain founded_year HQ Location
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain

Latest news on Zimvie

Frequently Asked Questions about ZimVie

ZimVie was founded in 2022.

ZimVie is headquartered in Westminster, United States.

Vafa Jamali is the current CEO of ZimVie.

As of Dec 31, 2024, the latest employee count at ZimVie is 1,770.

Annual revenue of ZimVie is $449.75M as on Dec 31, 2024.

Developer of implants for dental and spine treatment. It offers T3 pro dental implant, TSX implant, and Encode emmergence impression system for dental health. It offrs The Tether- Vertebral Body Tethering System for scoliosis and Mobi-C Cervical Disc for cervical disc replacement.

ZimVie's top competitors include Nevro, Paradigm Spine and ATEC Spine.

ZimVie offers Implant Systems, RealGUIDE Software, and RegenerOss Allograft Putty.

Yes, ZimVie is publicly traded on NASDAQ under the ticker symbol ZIMV.

ZimVie has 2 investors. Key investors include H.I.G. Capital, and ARCHIMED.

The ticker symbol of ZimVie is ZIMV on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available